SCOPUS 정보 검색 플랫폼

Neurology

Volumn 77, Issue 10, 2011, Pages 936-937

Historical controls in ALS trials: A high seas rescue?

(2) Donofrio, Peter D a Bedlack, Richard a

a VANDERBILT UNIVERSITY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; RILUZOLE; LITHIUM CARBONATE;

AGE; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; MEDICAL HISTORY; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SCORING SYSTEM; SEX; SURVIVAL; TREATMENT OUTCOME; FEMALE; MALE; MASS SCREENING; NOTE; PATHOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MASS SCREENING;

EID: 80055082117 PISSN: 00283878 EISSN: 1526632X Source Type: Journal
DOI: 10.1212/WNL.0b013e31822cfcb6 Document Type: Editorial

Times cited : (5)

References (9)

1
- 52749092495
- Bedlack RS, Pastula D, Welsh E, Pulley D, Cudkowicz M. Scrutinizing enrollment in ALS clinical trials: room for improvement? Amyotroph Lateral Scler 2008;9:257-265.
- (2008) Scrutinizing enrollment in ALS clinical trials: room for improvement? Amyotroph Lateral Scler , vol.9 , pp. 257-265
- Bedlack, R.S.¹ Pastula, D.² Welsh, E.³ Pulley, D.⁴ Cudkowicz, M.⁵

2
- 80055073951
- Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design
- Miller RG, Moore DH, Forshew DA, et al. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology 2011;77:973-979.
- (2011) Neurology , vol.77 , pp. 973-979
- Miller, R.G.¹ Moore, D.H.² Forshew, D.A.³

3
- 36148960127
- Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomised trial
- DOI 10.1016/S1474-4422(07)70270-3, PII S1474442207702703
- Gordon PH, Moore DH, Miller RG, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol 2007;6:1045-1053. (Pubitemid 350116691)
- (2007) Lancet Neurology , vol.6 , Issue.12 , pp. 1045-1053
- Gordon, P.H.¹ Moore, D.H.² Miller, R.G.³ Florence, J.M.⁴ Verheijde, J.L.⁵ Doorish, C.⁶ Hilton, J.F.⁷ Spitalny, G.M.⁸ MacArthur, R.B.⁹ Mitsumoto, H.¹⁰ Neville, H.E.¹¹ Boylan, K.¹² Mozaffar, T.¹³ Belsh, J.M.¹⁴ Ravits, J.¹⁵ Bedlack, R.S.¹⁶ Graves, M.C.¹⁷ McCluskey, L.F.¹⁸ Barohn, R.J.¹⁹ Tandan, R.²⁰ more..

4
- 3843145183
- Amyotrophic lateral sclerosis: A consensus viewpoint on designing and implementing a clinical trial
- DOI 10.1080/14660820410020187
- Leigh PN, Swash M, Iwasaki Y, et al. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial. ALS Other Motor Neuron Disord 2004;5:84-98. (Pubitemid 39545336)
- (2004) Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders , vol.5 , Issue.2 , pp. 84-98
- Leigh, P.N.¹ Swash, M.² Iwasaki, Y.³ Ludolph, A.⁴ Meininger, V.⁵ Miller, R.G.⁶ Mitsumoto, H.⁷ Shaw, P.⁸ Tashiro, K.⁹ Van Den Berg, L.¹⁰

5
- 67049096146
- Can we eliminate placebo in ALS clinical trials?
- Simmons Z. Can we eliminate placebo in ALS clinical trials? Muscle Nerve 2009;39:861-865.
- (2009) Muscle Nerve , vol.39 , pp. 861-865
- Simmons, Z.¹

6
- 33845430355
- The value of database controls in pilot or futility studies in ALS
- DOI 10.1212/01.wnl.0000244415.48221.81, PII 0000611420061128000023
- Czaplinski A, Haverkamp LJ, Yen AA, et al. The value of database controls in pilot or futility studies in ALS. Neurology 2006;67:1827-1832. (Pubitemid 44900761)
- (2006) Neurology , vol.67 , Issue.10 , pp. 1827-1832
- Czaplinski, A.¹ Haverkamp, L.J.² Yen, A.A.³ Simpson, E.P.⁴ Lai, E.C.⁵ Appel, S.H.⁶

7
- 77952190999
- Toward more efficient clinical trials for amyotrophic lateral sclerosis
- Cudkowicz ME, Katz J, Moore KH, et al. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:259-265.
- (2010) Amyotroph Lateral Scler , vol.11 , pp. 259-265
- Cudkowicz, M.E.¹ Katz, J.² Moore, K.H.³

8
- 0023777549
- There are no alternatives to double-blind controlled trials
- Noseworthy JH. There are no alternatives to double-blind controlled trials. Neurology 1988;38(suppl 2):76-79.
- (1988) Neurology , vol.38 , Issue.SUPPL. 2 , pp. 76-79
- Noseworthy, J.H.¹

9
- 67049107951
- A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis
- Gordon PH. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis. Muscle Nerve 2009;39:858-860.
- (2009) Muscle Nerve , vol.39 , pp. 858-860
- Gordon, P.H.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.